Indication
Disease Progression
1 clinical trial
1 product
1 drug
Clinical trial
Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Determine the Effect of Ferric Citrate on Time to a Composite Endpoint of Initiation of Maintenance Dialysis or All-cause Mortality vs Placebo in Adults With Advanced CKDStatus: Active (not recruiting), Estimated PCD: 2024-08-01
Product
Ferric CitrateDrug
Varlilumab